Method of combined treatment of glaucomatous optic neuropathy
RU2865243C1Active Publication Date: 2026-07-01FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA BASHKIRSKIJ GOSUDARSTVENNYJ MEDITSINSKIJ UNIV MINISTSTVA ZDRAVOOKHRANENIYA ROSSIJSKOJ FEDERATSII
Patent Information
- Application Number
- RU2025134753
- Authority / Receiving Office
- RU · RU
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-12-09
- Publication Date
- 2026-07-01
- Estimated Expiration
- 2045-12-09
Abstract
FIELD: medicine; ophthalmology.SUBSTANCE: retrobulbar injection of 2.0 ml of a suspension containing 50 mg of dispersed biomaterial “Alloplant for therapeutic sclerofilling” and 2.0 ml of sterile 0.9% sodium chloride solution is performed. The next day after the injection, endonasal electrophoresis of a 0.25% solution of the medication Retinalamin is performed at a current of 0.5–1 mA in a course of 10 daily procedures lasting from 3 to 15 minutes, while the medication Nooredit is administered orally at a dose of 150 mg 2 times a day for 30 days.EFFECT: achievement of a neuroprotective therapeutic effect, expressed in the stabilization and improvement of visual functions due to the combined effect on the local trophism of the optic nerve and the metabolism of the central parts of the visual analyzer.1 cl, 3 ex
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Method of retrosclerofilling of eyes with dispersed biomaterial "alloplant"
RU2610211C1
Method of the treatment of glaucoma optic neuropathy
RU2801496C1